Inflammation

, Volume 31, Issue 4, pp 266–272

Influenza Virus Infection and Risk of Acute Myocardial Infarction

  • Xiu-Ru Guan
  • Xin Li
  • Xiao-Min Xin
  • Li-Xin Jiang
  • Lan-Ying Cui
  • Lan-Feng Wang
  • Hong-Yuan Li
Article

Abstract

Increasing evidences have shown that pathogens might promote atherosclerosis and trigger acute myocardial infarction (AMI). But the conclusions from various studies on the correlation between previous influenza virus (IV) infection and AMI were inconsistent. We conducted a case-control study to assess the association of previous IV infection and AMI. Questionnaire survey was conducted to collect information about demographic characteristics and heart disease risk factors. Fasting blood sample was obtained to measure IgG antibodies to influenza virus A(IV-A), influenza virus B(IV-B), cytomegalovirus (CMV), herpes simplex virus type-1 (HSV-1) and type-2 (HSV-2), adenovirus (ADV), rubella virus (RV) and Chlamydia pneumoniae (CP) and measure the level of some biochemistry markers. Compared to controls, cases were more likely to have positive IgG antibodies to IV-A and IV-B (IV-A: OR, 3.3; 95%CI, 1.5 to 7.4; IV-B: OR, 17.2; 95%CI, 7.7 to 38.0). After adjustment for potential confounding variables, the risk of AMI was still associated with the presence of IgG antibodies to IV-A (adjusted OR, 7.5; 95%CI, 1.3 to 43.0) and IV-B (adjusted OR, 27.3; 95%CI, 6.6 to 113.8). The study supported the hypothesis that previous IV infection took part in the development of atherosclerosis and trigger the occurrence of AMI.

KEY WORDS

influenza virus infection atherosclerosis acute myocardial infarction 

References

  1. 1.
    Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115–126.PubMedCrossRefGoogle Scholar
  2. 2.
    Epstein, S. E., Y. F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:e20–e28.PubMedGoogle Scholar
  3. 3.
    Saikku, P. 2002. Seroepidemiology in Chlamydia pneumoniae–atherosclerosis association. Eur. Heart. J. 23:263–264.PubMedCrossRefGoogle Scholar
  4. 4.
    Kuo, C. C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841–849.PubMedGoogle Scholar
  5. 5.
    Oshima, T., R. Ozono, Y. Yano, Y. Oishi, H. Teragawa, Y. Higashi, M. Yoshizumi, and M. Kambe. 2005. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J. Am. Coll. Cardiol. 45:1219–1222.PubMedCrossRefGoogle Scholar
  6. 6.
    Chiu, B. 1999. Multiple infections in carotid atherosclerotic plaques. Am. Heart J. 138:S534–S536.PubMedCrossRefGoogle Scholar
  7. 7.
    Deshpande, R. G., M. B. Khan, and C. A. Genco. 1998. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immunol. 66:5337–5343.Google Scholar
  8. 8.
    Nieto, F. J., E. Adam, P. Sorlie, H. Farzadegan, J. L. Melnick, G. W. Comstock, and M. Szklo. 1996. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922–927.PubMedGoogle Scholar
  9. 9.
    Siscovick, D. S., S. M. Schwartz, L. Corey, J. T. Grayston, R. Ashley, S. P. Wang, B. M. Psaty, R. P. Tracy, L. H. Kuller, and R. A. Kronmal. 2000. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation 102:2335–2340.PubMedGoogle Scholar
  10. 10.
    Zhu, J., F. J. Nieto, B. D. Horne, J. L. Anderson, J. B. Muhlestein, and S. E. Epstein. 2001. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45–51.PubMedGoogle Scholar
  11. 11.
    Zhu, J., A. A. Quyyumi, J. E. Norman, R. Costello, G. Csako, and S. E. Epstein. 2000. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J. Infect. Dis. 182:1583–1587.PubMedCrossRefGoogle Scholar
  12. 12.
    Auer, J., R. Berent, T. Weber, and B. Eber. 2002. Influenza virus infection, infectious burden, and atherosclerosis. Stroke 33:1454–1455.PubMedCrossRefGoogle Scholar
  13. 13.
    Lavallée, P., V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco. 2002. Association between influenza vaccination and reduced risk of brain infarction. Stroke 33:513–518.PubMedCrossRefGoogle Scholar
  14. 14.
    Auer, J., M. Leitinger, R. Berent, W. Prammer, T. Weber, E. Lassnig, and B. Eber. 2002. Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography. Heart Dis. 4:349–354.PubMedCrossRefGoogle Scholar
  15. 15.
    Madjid, M., M. Naghavi, S. Litovsky, and S. W. Casscells. 2003. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 108:2730–2736.PubMedCrossRefGoogle Scholar
  16. 16.
    Collins, S. D. 1932. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Pub. Health Rep. 47:2159–2180.Google Scholar
  17. 17.
    Gross, P. A., A. W. Hermogenes, H. S. Sacks, J. Lau, and R. A. Levandowski. 1995. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann. Intern. Med. 123:518–527.PubMedGoogle Scholar
  18. 18.
    Alpert, J. S., K. Thygesen, E. Antman, and J. P. Bassand. 2000. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of Myocardial Infarction. J. Am. Coll. Cardiol. 36:959–969.PubMedCrossRefGoogle Scholar
  19. 19.
    Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 2003. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:S5–S20.CrossRefGoogle Scholar
  20. 20.
    Whitworth, J. A., and World Health Organization, International Society of Hypertension Writing Group. 2003. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21:1983–1992.PubMedCrossRefGoogle Scholar
  21. 21.
    Naghavi, M., Z. Barlas, S. Siadaty, S. Naguib, M. Madjid, and W. Casscells. 2000. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102:3039–3045.PubMedGoogle Scholar
  22. 22.
    Van Lenten, B. J., A. C. Wagner, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman. 2001. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 103:2283–2288.PubMedGoogle Scholar
  23. 23.
    Van Lenten, B. J., A. C. Wagner, G. M. Anantharamaiah, D. W. Garber, M. C. Fishbein, L. Adhikary, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman. 2002. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 106:1127–1132.PubMedCrossRefGoogle Scholar
  24. 24.
    Bouwman, J. J., F. L. Visseren, M. C. Bosch, K. P. Bouter, and R. J. Diepersloot. 2002. Procoagulant and inflammatory response of virus-infected monocytes. Eur. J. Clin. Invest. 32:759–766.PubMedCrossRefGoogle Scholar
  25. 25.
    Visseren, F. L., J. J. Bouwman, K. P. Bouter, R. J. Diepersloot, P. H. de Groot, and D. W. Erkelens. 2000. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb. Haemost. 84:319–324.PubMedGoogle Scholar
  26. 26.
    Naghavi, M., P. Wyde, S. Litovsky, M. Madjid, A. Akhtar, S. Naguib, M. S. Siadaty, S. Sanati, and W. Casscells. 2003. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 107:762–768.PubMedCrossRefGoogle Scholar
  27. 27.
    Nichol, K. L., J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane. 2003. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 348:1322–1332.PubMedCrossRefGoogle Scholar
  28. 28.
    Gurfinkel, E. P., R. L. de la Fuente, O. Mendiz, and B. Mautner. 2002. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105:2143–2147.PubMedCrossRefGoogle Scholar
  29. 29.
    Davis, M. M., K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, H. M. Krumholz, American Heart AssociationAmerican College of Cardiology. 2006. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/ American College of Cardiology. Circulation 114:1549–1553.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Xiu-Ru Guan
    • 1
  • Xin Li
    • 3
  • Xiao-Min Xin
    • 1
  • Li-Xin Jiang
    • 1
  • Lan-Ying Cui
    • 1
  • Lan-Feng Wang
    • 2
  • Hong-Yuan Li
    • 3
    • 4
  1. 1.Department of Laboratory DiagnosticsThe First Affiliated Hospital of Harbin Medical UniversityHarbinChina
  2. 2.Cardiovascular DepartmentThe First Affiliated Hospital of Harbin Medical UniversityHarbin, Heilongjiang ProvinceChina
  3. 3.Department of Epidemiology, College of Public HealthHarbin Medical UniversityHarbinChina
  4. 4.Department of Epidemiology, College of Public HealthHarbin Medical UniversityHarbinChina

Personalised recommendations